Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue    
Revenue
Other Revenue 1,030 1,144
Total revenue 1,030 1,144
Operating expenses:    
Research and development, net of reimbursements 23,135 18,031
General and administrative 11,999 8,077
Total operating expenses 35,134 26,108
Loss from operations (34,104) (24,964)
Other income:    
Interest income - net 1,087 190
Total other income 1,087 190
Net loss $ (33,017) $ (24,774)
Net loss per common share - basic and diluted (in Dollars per share) $ (1.37) $ (1.2)
Weighted average common shares outstanding - basic and diluted (in Shares) 24,141,545 20,568,373